×
Glaukos Inventory 2014-2024 | GKOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Glaukos inventory for the quarter ending September 30, 2024 was
$0.060B
, a
50.56% increase
year-over-year.
Glaukos inventory for 2023 was
$0.042B
, a
10.95% increase
from 2022.
Glaukos inventory for 2022 was
$0.038B
, a
64.45% increase
from 2021.
Glaukos inventory for 2021 was
$0.023B
, a
45.56% increase
from 2020.
View More
Glaukos Inventory 2014-2024 | GKOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Glaukos inventory for 2023 was
$0.042B
, a
10.95% increase
from 2022.
Glaukos inventory for 2022 was
$0.038B
, a
64.45% increase
from 2021.
Glaukos inventory for 2021 was
$0.023B
, a
45.56% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$217.3B
Intuitive Surgical (ISRG)
$204B
Alcon (ALC)
$45.1B
Edwards Lifesciences (EW)
$42B
IQVIA Holdings (IQV)
$35.9B
IDEXX Laboratories (IDXX)
$34.3B
DexCom (DXCM)
$33.8B
Waters (WAT)
$24B
STERIS (STE)
$21.7B
SONOVA HOLDING (SONVY)
$20.8B
Hologic (HOLX)
$16.1B
Fresenius Medical Care AG KGaA (FMS)
$14.6B
Globus Medical (GMED)
$12.6B
Sysmex ADR (SSMXY)
$12.2B
Penumbra (PEN)
$10.4B
Masimo (MASI)
$9.5B
Teleflex (TFX)
$8.4B
Integer Holdings (ITGR)
$4.8B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$3.8B
Veracyte (VCYT)
$3.4B
LivaNova (LIVN)
$2.8B
Nihon Kohden (NHNKY)
$2.6B
Tandem Diabetes Care (TNDM)
$2.4B
Elekta AB (EKTAY)
$2.3B
TransMedics (TMDX)
$2.2B
Integra LifeSciences Holdings (IART)
$2B
Alphatec Holdings (ATEC)
$1.7B
Artivion (AORT)
$1.3B
RxSight (RXST)
$1.3B